154 related articles for article (PubMed ID: 8903945)
1. A selective protein kinase C inhibitor (CGP 41251) positively and negatively modulates melanoma cell MSH receptors.
Siegrist W; Sauter P; Eberle AN
J Recept Signal Transduct Res; 1995; 15(1-4):283-96. PubMed ID: 8903945
[TBL] [Abstract][Full Text] [Related]
2. Homologous and heterologous regulation of alpha-melanocyte-stimulating hormone receptors in human and mouse melanoma cell lines.
Siegrist W; Stutz S; Eberle AN
Cancer Res; 1994 May; 54(10):2604-10. PubMed ID: 8168086
[TBL] [Abstract][Full Text] [Related]
3. Homologous regulation of the MSH receptor in melanoma cells.
Siegrist W; Eberle AN
J Recept Res; 1993; 13(1-4):263-81. PubMed ID: 8383755
[TBL] [Abstract][Full Text] [Related]
4. Characterization of receptors for alpha-melanocyte-stimulating hormone on human melanoma cells.
Siegrist W; Solca F; Stutz S; Giuffrè L; Carrel S; Girard J; Eberle AN
Cancer Res; 1989 Nov; 49(22):6352-8. PubMed ID: 2804981
[TBL] [Abstract][Full Text] [Related]
5. CGP 41251 and tamoxifen selectively inhibit mitogen-activated protein kinase activation and c-Fos phosphoprotein induction by substance P in human astrocytoma cells.
Luo W; Sharif TR; Houghton PJ; Sharif M
Cell Growth Differ; 1997 Nov; 8(11):1225-40. PubMed ID: 9372245
[TBL] [Abstract][Full Text] [Related]
6. Interactions of alpha-melanotropin and agouti on B16 melanoma cells: evidence for inverse agonism of agouti.
Siegrist W; Drozdz R; Cotti R; Willard DH; Wilkison WO; Eberle AN
J Recept Signal Transduct Res; 1997; 17(1-3):75-98. PubMed ID: 9029482
[TBL] [Abstract][Full Text] [Related]
7. Induction of constitutive melanogenesis in amelanotic mouse melanoma cells by transfection of the human melanocortin-1 receptor gene.
Chluba-de Tapia J; Bagutti C; Cotti R; Eberle AN
J Cell Sci; 1996 Aug; 109 ( Pt 8)():2023-30. PubMed ID: 8856498
[TBL] [Abstract][Full Text] [Related]
8. Stable expression of the human MSH receptor in a mouse melanoma cell line.
Chluba-de Tapia J; Bagutti C; Wikberg JS; Chhajlani V; Eberle AN
J Recept Signal Transduct Res; 1995; 15(1-4):43-53. PubMed ID: 8903930
[TBL] [Abstract][Full Text] [Related]
9. Melanotropin receptors of murine melanoma characterized in cultured cells and demonstrated in experimental tumors in situ.
Tatro JB; Entwistle ML; Lester BR; Reichlin S
Cancer Res; 1990 Feb; 50(4):1237-42. PubMed ID: 2153454
[TBL] [Abstract][Full Text] [Related]
10. Binding and internalization of the melanocyte stimulating hormone receptor ligand [Nle4, D-Phe7] alpha-MSH in B16 melanoma cells.
Wong W; Minchin RF
Int J Biochem Cell Biol; 1996 Nov; 28(11):1223-32. PubMed ID: 9022281
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of the growth of glioblastomas by CGP 41251, an inhibitor of protein kinase C, and by a phorbol ester tumor promoter.
Begemann M; Kashimawo SA; Choi YA; Kim S; Christiansen KM; Duigou G; Mueller M; Schieren I; Ghosh S; Fabbro D; Lampen NM; Heitjan DF; Schiff PB; Bruce JN; Weinstein IB
Clin Cancer Res; 1996 Jun; 2(6):1017-30. PubMed ID: 9816263
[TBL] [Abstract][Full Text] [Related]
12. B16-G4F mouse melanoma cells: an MSH receptor-deficient cell clone.
Solca FF; Chluba-de Tapia J; Iwata K; Eberle AN
FEBS Lett; 1993 May; 322(2):177-80. PubMed ID: 8482388
[TBL] [Abstract][Full Text] [Related]
13. Alpha-melanocyte stimulating hormone-induced pigmentation is blocked by depletion of protein kinase C.
Park HY; Russakovsky V; Ao Y; Fernandez E; Gilchrest BA
Exp Cell Res; 1996 Aug; 227(1):70-9. PubMed ID: 8806453
[TBL] [Abstract][Full Text] [Related]
14. Characterisation of novel human lung carcinoma cell lines selected for resistance to anti-neoplastic analogues of staurosporine.
Courage C; Bradder SM; Jones T; Schultze-Mosgau MH; Gescher A
Int J Cancer; 1997 Nov; 73(5):763-8. PubMed ID: 9398059
[TBL] [Abstract][Full Text] [Related]
15. Expression of melanocyte stimulating hormone receptors correlates with mammalian pigmentation, and can be modulated by interferons.
Kameyama K; Montague PM; Hearing VJ
J Cell Physiol; 1988 Oct; 137(1):35-44. PubMed ID: 2459141
[TBL] [Abstract][Full Text] [Related]
16. Transcriptional induction of the melanocyte-stimulating hormone receptor in brain metastases of murine K-1735 melanoma.
Radinsky R; Beltran PJ; Tsan R; Zhang R; Cone RD; Fidler IJ
Cancer Res; 1995 Jan; 55(1):141-8. PubMed ID: 7805024
[TBL] [Abstract][Full Text] [Related]
17. Antitumor activity of the new selective protein kinase C inhibitor 4'-N-benzoyl staurosporine on murine and human tumor models.
Ikegami Y; Yano S; Nakao K; Fujita F; Fujita M; Sakamoto Y; Murata N; Isowa K
Arzneimittelforschung; 1995 Nov; 45(11):1225-30. PubMed ID: 8929245
[TBL] [Abstract][Full Text] [Related]
18. Interaction of an alpha-melanocyte-stimulating hormone-diphtheria toxin fusion protein with melanotropin receptors in human melanoma metastases.
Tatro JB; Wen Z; Entwistle ML; Atkins MB; Smith TJ; Reichlin S; Murphy JR
Cancer Res; 1992 May; 52(9):2545-8. PubMed ID: 1314697
[TBL] [Abstract][Full Text] [Related]
19. A protein kinase C inhibitor induces phenotypic reversion of ras-transformed pancreatic cancer cells and cooperatively blocks tumor cell proliferation with an anti- ras peptide.
Way D; Smith S; Sivendran S; Chie L; Kanovsky M; Brandt-Rauf PW; Chung DL; Michl J; Pincus MR
Cancer Chemother Pharmacol; 2002 Jun; 49(6):429-37. PubMed ID: 12107546
[TBL] [Abstract][Full Text] [Related]
20. In situ melanin assay for MSH using mouse B16 melanoma cells in culture.
Siegrist W; Eberle AN
Anal Biochem; 1986 Nov; 159(1):191-7. PubMed ID: 3812999
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
